These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 4321789)

  • 21. The amoebicidal, trichomonicidal, and antibacterial effects of niridazole in laboratory animals.
    Kradolfer F; Jarumilinta R; Sackmann W
    Ann N Y Acad Sci; 1969 Oct; 160(2):740-8. PubMed ID: 4241973
    [No Abstract]   [Full Text] [Related]  

  • 22. Chemotherapeutically active anthraquinones. II. Aminomethylanthraquinones.
    Winkelmann E; Raether W
    Arzneimittelforschung; 1986 Feb; 36(2):234-47. PubMed ID: 3964330
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tinidazole and metronidazole pharmocokinetics in man and mouse.
    Taylor JA; Migliardi JR; Von Wittenau MS
    Antimicrob Agents Chemother (Bethesda); 1969; 9():267-70. PubMed ID: 5396499
    [No Abstract]   [Full Text] [Related]  

  • 24. Tinidazole: a review of its antiprotozoal activity and therapeutic efficacy.
    Sawyer PR; Brogden RN; Pinder RM; Speight TM; Avery GS
    Drugs; 1976; 11(6):423-40. PubMed ID: 954609
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Metronidazole and nitrimidazine.
    Bénazet F; Guillaume L
    Lancet; 1972 Mar; 1(7750):597. PubMed ID: 4110081
    [No Abstract]   [Full Text] [Related]  

  • 26. Chemotherapeutically active nitro compounds. 4. 5-Nitroimidazoles (Part I).
    Winkelmann E; Raether W; Gebert U; Sinharay A
    Arzneimittelforschung; 1977; 27(12):2251-63. PubMed ID: 203293
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Perspectives in the treatment of protozoal diseases resistant to metronidazole.
    De Carneri I
    Trans R Soc Trop Med Hyg; 1971; 65(2):268-70. PubMed ID: 5557356
    [No Abstract]   [Full Text] [Related]  

  • 28. Drug repositioning for novel antitrichomonas from known antiprotozoan drugs using hierarchical screening.
    Meneses-Marcel A; Marrero-Ponce Y; Ibáñez-Escribano A; Gómez-Barrio A; Escario JA; Barigye SJ; Terán E; García-Jacas CR; Machado-Tugores Y; Nogal-Ruiz JJ; Arán-Redó VJ
    Future Med Chem; 2018 Apr; 10(8):863-878. PubMed ID: 29589477
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 2,2'-hydrazobis(5-nitrothiazoles) and analogs, a new type of antiprotozoal agents.
    Avramoff M; Adler S; Foner A
    J Med Chem; 1967 Nov; 10(6):1138-43. PubMed ID: 4293496
    [No Abstract]   [Full Text] [Related]  

  • 30. Nitro-imidazole in protozoal infections (amoebiasis, giardiasis and trichomoniasis).
    Abd-Rabbo H; Montasir M; Abaza H; el-Gohary Y
    J Trop Med Hyg; 1969 Nov; 72(11):271-6. PubMed ID: 5357261
    [No Abstract]   [Full Text] [Related]  

  • 31. [Activity of Nifurmazole (CB 10,615) on Trypanosoma equiperdum, Schizotrypanum cruzi and Trypanosoma gambiense].
    Vindel J; Catalan F; Navarro J; Siou G
    C R Acad Hebd Seances Acad Sci D; 1970 May; 270(20):2512-5. PubMed ID: 4987585
    [No Abstract]   [Full Text] [Related]  

  • 32. [Medical treatment of amebiasis].
    Cervantes LF
    Arch Invest Med (Mex); 1972; 2():Suppl 2:415-26. PubMed ID: 4349101
    [No Abstract]   [Full Text] [Related]  

  • 33. Case Report: Endemic Amebiasis in Australia: Implications for Residents, Travelers, and Clinicians.
    Smith S; Phillips GE; McBride WJH; Hanson J
    Am J Trop Med Hyg; 2017 Jul; 97(1):245-247. PubMed ID: 28719303
    [No Abstract]   [Full Text] [Related]  

  • 34. Tinidazole, a new antiprotozoal agent: Effect on Trichomonas and other protozoa.
    Howes HL; Lynch JE; Kivlin JL
    Antimicrob Agents Chemother (Bethesda); 1969; 9():261-6. PubMed ID: 5396498
    [No Abstract]   [Full Text] [Related]  

  • 35. Current and future perspectives on the chemotherapy of the parasitic protozoa Trichomonas vaginalis and Entamoeba histolytica.
    Moya IA; Su Z; Honek JF
    Future Med Chem; 2009 Jul; 1(4):619-43. PubMed ID: 21426030
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthesis and antiprotozoal activity of 1-(3-chloro-2-hydroxypropyl)-substituted nitroimidazoles.
    Hoffer M; Grunberg E
    J Med Chem; 1974 Sep; 17(9):1019-20. PubMed ID: 4370421
    [No Abstract]   [Full Text] [Related]  

  • 37. [New derivatives with antitrichomonas activity].
    Genova R; Coppi G; Marazzi-Uberti E
    Boll Soc Ital Biol Sper; 1967 Aug; 43(16):956-9. PubMed ID: 6073452
    [No Abstract]   [Full Text] [Related]  

  • 38. Antiamebic and antitrichomonal studies on the antibiotic paromomycin (humatin) in vitro and in experimental animals.
    THOMPSON PE; BAYLES A; HERBST SF; OLSZEWSKI B; MEISENHELDER JE
    Antibiot Chemother (Northfield); 1959 Oct; 9():618-26. PubMed ID: 13838099
    [No Abstract]   [Full Text] [Related]  

  • 39. [A new antitrichomonal agent, tinidazole].
    Di Carlo R
    G Batteriol Virol Immunol; 1974; 67(7-12):257-72. PubMed ID: 4377559
    [No Abstract]   [Full Text] [Related]  

  • 40. The activity of fexinidazole (HOE 239) against experimental infections with Trypanosoma cruzi, trichomonads and Entamoeba histolytica.
    Raether W; Seidenath H
    Ann Trop Med Parasitol; 1983 Feb; 77(1):13-26. PubMed ID: 6411009
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.